Drawing for IDERA

USPTO serial 88631158

IDERA

Reviewed by CopyMark Law Group

Reg. 6223085Status 700Renewal
Filing date
Status date
Registration date
Dec 15, 2020
Examiner
DUBRAY, KATHERINE M
Law office
PUBLICATION AND ISSUE SECTION

What this means

This registration is in, or will soon enter, a USPTO maintenance window. Missing a Section 8 or Section 9 filing can cancel the registration.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with IDERA?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Get help with this Renewal, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $299*

Plus Government fees of $325

Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Rebecca E. McDougall

Rebecca E. McDougall MORGAN, LEWIS & BOCKIUS LLP1111 PENNSYLVANIA AVENUE NWWASHINGTON, DC 20004UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
005Medical therapeutic preparations, namely, biologically active modulators, biologically active immune modulators, biologically active antisense DNA or RNA compounds, chemical modulators of gene expression working at DNA transcription, RNA or translation processes; immunomodulatory oligonucleotides, namely, ingredients that enhance or induce an immune response as a component part in a pharmaceutical preparation; pharmaceutical and vaccine adjuvants to enhance the immune system response; pharmaceuticals for use in the treatment of viral and bacterial infection, inflammatory disorders and diseases, cancer, and auto immune diseases and disorders and vaccine adjuvants to modulate the immune system; biologically active pharmaceutical compounds for use in the treatment of viral and bacterial infection or diseases associated with cellular gene expressions by preventing the production of disease associated proteins made by said infectious agents or cellular genesACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Dec 15, 2025REM1COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED—
Dec 15, 2020R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Nov 7, 2020SUNANOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED—
Nov 6, 2020CNPRALLOWED PRINCIPAL REGISTER - SOU ACCEPTED—
Oct 15, 2020SUPCSTATEMENT OF USE PROCESSING COMPLETE—
Oct 15, 2020AITUCASE ASSIGNED TO INTENT TO USE PARALEGAL—
Sep 29, 2020IUAFUSE AMENDMENT FILED—
Sep 29, 2020EISUTEAS STATEMENT OF USE RECEIVEDThe applicant filed a Statement of Use with specimens showing the mark in actual commerce. The USPTO will review the filing for compliance. If accepted, the mark can proceed to registration; if deficient, the USPTO may issue a requirement or office action.
Mar 31, 2020NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Feb 4, 2020NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Feb 4, 2020PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Jan 15, 2020NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Dec 27, 2019CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Dec 27, 2019DOCKASSIGNED TO EXAMINER—
Oct 2, 2019MDSCNOTICE OF DESIGN SEARCH CODE E-MAILED—
Oct 1, 2019NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Sep 28, 2019NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance